Plexium
Plexium is a biotechnology company focused on the identification of E3 ligase modulating small molecules to treat cancer and neurodegenerative diseases. The company's screening platform, named DELPhe for DNA-Encoded Library phenotypic screening, utilizes droplet and microwell confinement to miniaturize cell-based assays that yield high content readouts at very low cost and very high throughput.
Last updated on
About Plexium
Founded
2018Estimated Revenue
$10M-$50MEmployees
51-250Funding / Mkt. Cap
$165MCategory
Sector
Health CareIndustry Group
Pharmaceuticals, Biotechnology & Life SciencesIndustry
BiotechnologySIC Code
73NAICs Code
51Location
City
San DiegoState
CaliforniaCountry
United StatesPlexium
Find your buyer within Plexium